LONDON, 17 February 2021 – Smiths Detection, a global leader in threat detection and security screening technologies, today reports that its BioFlash® Biological Identifier is capable of detecting SARS-CoV-2 in the air following tests conducted by the United States Army Medical Research Institute of Infectious Diseases (USAMRIID)
17 February, 2021
Stockholm, February 03, 2021: Molecular diagnostics firm Elypta announced today the launch of the first standardized testing service based on a RUO liquid biopsy for full spectrum glycosaminoglycan quantification for researchers. Elypta is also launching a sponsorship program to support more academic research in the field, prioritizing fundamental, pre-clinical, and clinical questions about how glycosaminoglycans relate to cancer.
08 February, 2021